AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
HUMAN ALBUMIN
13 registrations across 4 African markets— 13 active
Markets with HUMAN ALBUMIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ALBUCEL Solution For Injection | 🇰🇪Kenya | INTAS PHARMACEUTICALS LIMITED | active | Feb 2031 |
| ALBUSOL 20% HUMAN ALBUMIN (FRACTION V PASTE) | 🇬🇭Ghana | — | active | Jan 2031 |
| ALBUSOL 20% HUMAN ALBUMIN (FRACTION V PASTE) | 🇬🇭Ghana | — | active | Jan 2031 |
| ALBIOMIN 20% SOLUTION FOR INTRAVENOUS INJECTION (HUMAN ALBUMIN 200G/L) | 🇬🇭Ghana | — | active | Jul 2030 |
| ALBIOMIN 5% SOLUTION FOR INTRAVENOUS INJECTION (HUMAN ALBUMIN 50G/L) | 🇬🇭Ghana | — | active | Jul 2030 |
| ALBIOMIN 20% SOLUTION FOR INTRAVENOUS INJECTION (HUMAN ALBUMIN 200G/L) | 🇬🇭Ghana | — | active | Jul 2030 |
| ALBIOMIN 5% SOLUTION FOR INTRAVENOUS INJECTION (HUMAN ALBUMIN 50G/L) | 🇬🇭Ghana | — | active | Jul 2030 |
| HUMAN ALBUMIN PARENTERAL
ORDINARY
INFUSION
VIALS/BOTTLES | 🇺🇬Uganda | BIOFARMA PLASMA LIMITED LIABILITY COMPANY | active | — |
| HUMAN ALBUMIN PARENTERAL
ORDINARY
INFUSION
VIALS/BOTTLES | 🇺🇬Uganda | BIOFARMA PLASMA LIMITED LIABILITY COMPANY | active | — |
| HUMAN ALBUMIN PARENTERAL
ORDINARY
INFUSION
VIALS/BOTTLES | 🇺🇬Uganda | OCTAPHARMA AG | active | — |
| ALBUCEL liquid injection | 🇹🇿Tanzania | Intas Pharmaceuticals Limited | active | — |
| HUMAN ALBUMIN PARENTERAL
ORDINARY
INFUSION
VIALS/BOTTLES | 🇺🇬Uganda | OCTAPHARMA AG | active | — |
| Albunorm 20 Solution for injection | 🇹🇿Tanzania | Octapharma AG. | active | — |
HUMAN ALBUMIN in Africa — Regulatory Overview
HUMAN ALBUMIN is registered across 4 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Uganda, Tanzania, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 13 registrations, 13 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.